Image – Interventional flashlight

DOI: 10.4244/EIJ-D-18-00400

Bioresorbable magnesium scaffold in complex PCI in a nickel allergy patient: one-year follow-up – no disease, no scaffolds

Jeremías Bayón1, MD; Melisa Santás-Álvarez1, MD; Raymundo Ocaranza-Sánchez1, MD, PhD; Carlos González-Juanatey1, MD, PhD

Figure 1. Angiographic and OCT images over time. A) Coronary angiography showing coronary artery disease in the LAD and LCX at baseline and at three months with good result of implanted scaffolds, and at one-year follow-up, with no evidence of restenosis. B) Optical coherence tomography (OCT) post PCI, at three-month and one-year follow-up. Cross-sections are divided into proximal LAD (1), LAD bifurcated with diagonal (2), mid LAD overlapping scaffold (3) and LCX (4). At baseline circle arrowheads indicate correct apposition of the struts. At three months, dotted line arrows indicate partial covering of the majority of the struts and arrowheads indicate two layers of struts in overlapping cross-sections. At one year, solid arrows (magnified image) indicate the last remnants of the magnesium backbone degradation process without evidence of Magmaris scaffold struts. Asterisk (*): diagonal lumen. LAD: left anterior descending; LCX: left circumflex

The bioresorbable sirolimus-eluting magnesium scaffold (Magmaris; Biotronik AG, Bülach, Switzerland) has a metallic magnesium skeleton with a thickness/width of 150 µm/150 µm1. The absorption time is fast: 95% will be absorbed in the first twelve months2.

A report on successful bifurcation lesion treatment with the Magmaris has been published previously3; however, there is little literature on complex percutaneous coronary intervention (PCI), such as coronary dissections, with this device4, and no previous reports in chronic total occlusion (CTO).

We present the case of a 65-year-old male with an allergy to nickel, coronary disease of two vessels with multiple tandem lesions in the left anterior descending (LAD) artery, and CTO in the left circumflex (LCX) artery. The patient was discussed by the Heart Team, who concluded that the diffuse vessel disease was not suitable for grafting. Coronary angiography (at baseline, three months post PCI and at one-year follow-up) is shown in Figure 1A.

We treated the LAD with sequential and overlapping Magmaris scaffolds, implanting from the distal LAD to the bifurcation with the diagonal, which was treated with a two-scaffold technique – the first implanted in the diagonal branch and the second one in the mid LAD. Total occlusion of the LCX was also treated with the Magmaris.

The final result was confirmed by optical coherence tomography (OCT), post PCI, at three months and at one-year follow-up (Figure 1B). Post-PCI OCT showed 2.1% malapposed struts within Magmaris scaffolds. At three months, we reviewed strut coverage with 82% endothelialisation. Post-PCI OCT indicated correct apposition of the struts (circle arrowheads). Three-month OCT showed partial covering of the majority of the struts (dotted line arrows). Twelve-month OCT showed the remnants of the magnesium backbone degradation process (solid arrows) without evidence of Magmaris scaffold struts. Use of the Magmaris scaffold is becoming a real and safe choice in this kind of patient.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 15 Number 7
Sep 20, 2019
Volume 15 Number 7
View full issue


Key metrics

Suggested by Cory

Image – Interventional flashlight

10.4244/EIJ-D-18-00501 Jul 19, 2019
“Bumpy” neointima: the fingerprint of bioabsorbable magnesium scaffold resorption
Alfonso F et al
free

10.4244/EIJV16I11A162 Dec 4, 2020
Magnesium-based bioresorbable scaffolds in STEMI. The quest for the optimal bioresorption balance
Gonzalo N and McInerney A
free

IMAGE IN CARDIOLOGY

10.4244/EIJV10I4A84 Aug 19, 2014
Novel indication for bioabsorbable scaffolds in metal allergy
Patel N et al
free

Short report

10.4244/EIJ-D-19-00421 Jan 20, 2021
Target lesion revascularisation of bioresorbable metal scaffolds: a case series study and literature review
Ortega-Paz L et al
free
Trending articles
309.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.2

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
72.85

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
58.3

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved